Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
ID: 351620Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for investigator-initiated clinical trials focused on complementary and integrative health interventions delivered remotely or through mobile health (mHealth) technologies. This funding opportunity encourages applications for rigorously designed clinical trials that do not require in-person interactions between research staff and participants, emphasizing the need for justification of remote delivery methods and preliminary data on feasibility, safety, and potential clinical benefits. The initiative aims to advance research in health disparities and innovative intervention delivery methods, requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application. Key dates include an opening date of January 20, 2024, and a close date of November 17, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Center for Complementary and Integrative Health (NCCIH), has issued a Notice of Funding Opportunity (NOFO) for investigator-initiated clinical trials exploring complementary and integrative health interventions delivered remotely or via mobile health (mHealth) technologies. The competitive funding opportunity (PAR-24-086) encourages applications focused on rigorously designed clinical trials that do not require in-person interactions between research staff and participants. Investigators must provide justification for remote delivery methods and compile preliminary data to ensure feasibility, safety, and the potential clinical benefit of proposed interventions. The funding supports diverse approaches, including mind and body interventions and multi-component therapies. A critical requirement involves submitting a Plan for Enhancing Diverse Perspectives (PEDP), emphasizing inclusivity throughout project execution. Applications must adhere to stringent guidelines, including substantial preliminary data, robust trial designs, and compliance with U.S. FDA regulations where applicable. Key application dates are identified, including an opening date of January 20, 2024, and grant expiration on November 18, 2026, indicating a structured timeline for submission and review processes. This initiative reinforces NIH's commitment to advancing research and addressing health disparities through innovative intervention delivery methods.
    Similar Opportunities
    Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for investigator-initiated clinical trials focused on complementary and integrative health interventions delivered remotely or via mobile health (mHealth) technologies. Applicants are required to design fully powered clinical trials that do not involve in-person contact between research staff and participants, providing preliminary data on the feasibility, safety, and potential clinical benefits of their proposed interventions. This initiative aligns with the NIH's commitment to addressing public health challenges and expanding access to integrative health approaches, particularly in areas of high research priority identified by the National Center for Complementary and Integrative Health (NCCIH). Interested applicants should note that the submission period opens on January 20, 2025, and must include a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.
    Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)" aimed at promoting exploratory research on mobile health (mHealth) technologies in low- and middle-income countries (LMICs). This initiative seeks to develop, validate, and assess innovative mHealth interventions that utilize emerging technologies to improve health outcomes in LMICs, with a focus on fostering multidisciplinary research and building research capacity in these regions. Eligible applicants include a wide range of organizations, such as higher education institutions and community-based organizations, with a requirement for partnerships between U.S. institutions and LMIC researchers. The funding amount can reach up to $125,000, with applications due by March 20, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAR-23-318.html.
    Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)" aimed at encouraging exploratory research on mobile health (mHealth) interventions tailored for low- and middle-income countries (LMICs). The initiative seeks to develop, validate, and assess innovative mHealth technologies that can improve health outcomes in these regions, fostering partnerships between U.S. institutions and LMIC entities to enhance research capabilities and address global health challenges. Funding of up to $125,000 is available for R21 projects over two years, with the potential for an additional $200,000 per year in the R33 phase, contingent upon milestone completion. Applications will be accepted starting February 21, 2025, with a closing date of March 20, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Center for Complementary and Integrative Health (NCCIH), has announced a funding opportunity for multi-site feasibility clinical trials focused on mind and body interventions under the R01 grant mechanism. This initiative aims to support studies that gather essential data necessary for planning larger efficacy trials, with specific objectives including assessing recruitment feasibility, intervention fidelity, and participant adherence across multiple sites. The funding is crucial for advancing research in complementary and integrative health, addressing public health challenges, and fostering innovative healthcare approaches. Eligible applicants can request up to $350,000 in direct costs per year, with applications due by November 17, 2026. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-267.html.
    Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Center for Complementary and Integrative Health (NCCIH), is offering a funding opportunity for feasibility clinical trials focused on mind and body interventions addressing high-priority research topics. The objective is to support R34 planning grants that gather essential data necessary for the design and planning of future full-scale efficacy studies, specifically examining aspects such as intervention acceptability, recruitment strategies, and data collection procedures. This initiative is crucial for advancing research in nonpharmacological approaches to symptom management, particularly relevant in the context of increasing healthcare demands. Interested applicants can apply for grants of up to $450,000 over three years, with a submission deadline of November 13, 2026. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-084.html.
    NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for multi-site feasibility clinical trials of mind and body interventions through the National Center for Complementary and Integrative Health (NCCIH). This R01 research grant invites applications focused on investigating complementary health approaches that utilize physical or psychological therapies, with an emphasis on demonstrating prior feasibility data to support the multi-site approach. The initiative aims to enhance understanding of integrative health interventions, particularly their efficacy and impact on diverse populations and health disparities. Interested applicants can apply for a maximum project budget of $350,000 annually over a period not exceeding three years, with a submission deadline of January 20, 2024. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Laboratories to Optimize Digital Health" grant, aimed at enhancing the reach and effectiveness of digital mental health interventions. This initiative focuses on innovative research projects that leverage established digital health platforms to conduct clinical trials, ultimately seeking to address health disparities and improve mental health outcomes. The funding opportunity encourages collaboration and the development of scalable, technology-driven solutions, with no budget limits and a maximum project period of four years. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with applications due by March 5, 2025.
    Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Laboratories to Optimize Digital Health" initiative, aimed at enhancing the reach and effectiveness of digital mental health interventions through innovative research projects. This funding opportunity focuses on developing digital health test beds to optimize existing evidence-based interventions, particularly targeting vulnerable populations and addressing health disparities. The initiative supports clinical trials and encourages collaboration between software developers and researchers to understand the mechanisms of action behind these interventions. Applications open on January 5, 2025, with multiple due dates leading to awards expected to begin in July 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at NIH Grants.
    Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Center for Complementary and Integrative Health (NCCIH), is inviting applications for the R34 Planning Grant aimed at conducting feasibility clinical trials of mind and body interventions for high-priority research topics. The primary objective of this funding opportunity is to gather essential data necessary for planning future full-scale clinical efficacy or effectiveness studies, with a strong emphasis on addressing gaps in existing knowledge and enhancing public health outcomes, particularly for underserved populations. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and community-based organizations, with a funding limit of $450,000 over a maximum project period of three years. Interested parties should submit their applications by November 17, 2026, and are encouraged to contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)" aimed at developing medical technologies that address health disparities among underserved populations in the U.S. This initiative encourages grant applications focused on creating effective, affordable, culturally acceptable, and accessible medical solutions, including devices, imaging systems, and telehealth innovations, while emphasizing the importance of formal collaborations with healthcare organizations serving these populations. The NIH plans to allocate approximately $2.4 million for this initiative, with an award ceiling of $500,000 per project, and expects to fund 3-4 awards over a project duration of up to four years. Interested applicants must submit their proposals by May 2, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.